Contents

Search

ciclesonide (Omnaris, Alvesco, Zetonna)

Indications: - seasonal & perennial allergic rhinitis & atopy in adults & children 12 years of age & up (Omnaris) - asthma & COPD (Alvesco) [6] Dosage: - Nasal spray, 2 sprays QD - Zetona: 1 spray QD [5] - Inhalation aerosol (MDI): [4] a) start 80 ug (1 puff) BID b) maximum 320 ug (2 puffs) BID 80 ug/puff & 160 ug/puff Mechanism of action: - nasal glucocorticoid - inhaled glucocorticoid Notes: Manufacturer: Alta Pharma, Nycomed

Interactions

drug adverse effects of glucocorticoids monitor with drug (more general terms)

General

nasal glucocorticoid (nasal steroid)

Database Correlations

PUBCHEM correlations

References

  1. Prescriber's Letter 14(2): 2007 New drugs approved by the FDA in 2006 Detail-Document#: 2302213 (subscription needed) http://www.prescribersletter.com
  2. Prescriber's Letter 14(6): 2007 New Nasal Steroids: Veramyst and Omnaris Detail-Document#: 230610 (subscription needed) http://www.prescribersletter.com
  3. Prescriber's Letter 15(6): 2008 Nasal Sprays for Allergic Rhinitis Detail-Document#: 240609 (subscription needed) http://www.prescribersletter.com
  4. Prescriber's Letter 15(9): 2008 New Formulation: Alvesco (Ciclesonide Inhalation Aerosol) Detail-Document#: 240908 (subscription needed) http://www.prescribersletter.com
  5. Prescriber's Letter 19(9): 2012 Nasal Sprays for Allergic Rhinitis Detail-Document#: 280910 (subscription needed) http://www.prescribersletter.com
  6. Deprecated Reference